Rticc
Seleccione idioma:  
Buscar:
RTICC 2013
Programas RTICC
Agenda
Seguimiento cientifico
Ofertas de empleo y Agenda » Otras reuniones científicas
 
Pathology Meeting: Advances in Pathology and Molecular Diagnostics in the Era of Personalized Cancer Therapy

Date: October 5-7,  2016

Organizers: MD Anderson Cancer Center Madrid (Spain)

Venue: Mutua Madrileña Auditorium. Paseo de la Castellana, 33. Madrid, Spain.

Meeting Directors:  Dr. Joseph Khoury & Dr. Juan Fernando García García.

Call for platform presentations

We encourage young researchers to participate in the meeting by sending oral presentations.

The two best abstracts received will be granted with an economical reward.

Please check the guidelines on the website or kindly contact the technical secretariat forfurther information.

Deadline for abstract submission: September 15th, 2016

Target audience: The meeting is aimed at pathologists-in-training, molecular biologists, and medical andsurgical oncologists and surgeons.

Meeting secretariat: Doctaforum · Congresos y Reuniones Científicas. Monasterios de Suso y Yuso 34, 28049 Madrid. Tel.: +34 91 372 0203 · E-mail: pathologymeeting@doctaforum.com

Registrations: www.mdanderson.es/pathologymeeting

Program and more information: see program enclosed.

Documentos relacionados:
Reuniones RTICC
Congresos
Otras reuniones científicas
Ofertas de empleo
Becas
Documentos RTICC
Enlaces de interés
Avisos
Noticias
03/03/2017 | Otras reuniones
13/11/2016 | Otras reuniones
21/10/2016 | Reuniones RTICC
29/09/2016 | Becas
Publicaciones
RD12/0036/0053
Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?
Font R, Espinas JA, Layos L, Martinez Villacampa M, Capdevila J, Tobeña M, Pisa A, Pericay C, Lezcano C, Fort E, Cardona I, Berga N, Solà J, Borras JM
Ann Oncol  2017.  4.  831-835.  PMID: 28327898. 
RD12/0036/0053
Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study.
Prades J, Algara M, Espinàs JA, Farrús B, Arenas M, Reyes V, García-Reglero V, Cambra MJ, Rubio E, Anglada L, Eraso A, Pedro A, Fuentes-Raspall MJ, Tuset V, Solà J, Borras JM
Radiother Oncol  2017.  1.  22-28.  PMID: 28236538. 
RD12/0036/0053
Current developments in cancer care: including the patients' perspective-3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany.
Ortmann O, Rösler W, Helbig U, participants of the ERTM.
J Cancer Res Clin Oncol  2017.  4.  673-676.  PMID: 27988842. 
RD12/0036/0005
Snail1-expressing fibroblasts as a source of paracrine signals in colon cancer tumors
Herrera A, Herrera M, Alba-Castellón L, Silva J, García V, Loubat J, Alvarez-Cienfuegos A, García JM, Rodríguez R, Gil B, Citores MJ, Larriba MJ, Casal JI, García de Herreros A, Bonilla F, Peña C
  2014. 
Grupos colaboradores: RD12/0036/0005 , RD12/0036/0041
RD12/0036/0005
The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case.
Cebrià-Costa JP, Millanes-Romero A, de Herreros AG, Peiró S
Mol Cell Oncol  2014.  2.  e960770.  PMID: 27308335. 
RD12/0036/0005
Snail1 controls cooperative cell plasticity during metastasis.
Baulida J
Oncoscience  2015.  11.  898-9.  PMID: 26697515. 
RD12/0036/0005
Lysyl oxidase-like 2 (LOXL2) oxidizes trimethylated lysine 4 in histone H3.
Herranz N, Dave N, Millanes-Romero A, Pascual-Reguant L, Morey L, Díaz VM, Lórenz-Fonfría V, Gutierrez-Gallego R, Jerónimo C, Iturbide A, Di Croce L, García de Herreros A, Peiró S
FEBS J  2016.  23.  4263-4273.  PMID: 27735137. 
RD12/0036/0005
Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology.
Mateu-Jimenez M, Fermoselle C, Rojo F, Mateu J, Peña R, Urtreger AJ, Diament MJ, Joffé ED, Pijuan L, Herreros AG, Barreiro E
Curr Pharm Des  2016.  34.  5300-5310.  PMID: 27339432. 
Grupos colaboradores: RD12/0036/0005 , RD12/0036/0051
RD12/0036/0005
Snail1-Dependent Activation of Cancer-Associated Fibroblast Controls Epithelial Tumor Cell Invasion and Metastasis.
Alba-Castellón L, Olivera-Salguero R, Mestre-Farrera A, Peña R, Herrera M, Bonilla F, Casal JI, Baulida J, Peña C, García de Herreros A
Cancer Res  2016.  21.  6205-6217.  PMID: 27503928. 
Grupos colaboradores: RD12/0036/0005 , RD12/0036/0041
RD12/0036/0005
Antisense non-coding RNAs and regulation of gene transcription.
Beltran M, García de Herreros A
Transcription  2016.  2.  39-43.  PMID: 26985653. 
ISCII
ISCII
 
Ministerio de Economia y Competitividad
Descargar
Red Temática Investigación Cooperativa Sanitaria
Rticc 2012
Logotipos
  
ISCII
Red Temática Investigación Cooperativa en Cáncer (RTICC)
Centro de Investigación Cáncer - Campus Miguel de Unamuno - 37007 - Salamanca
(+34) 923294803 - sec.rticc[arroba]usal.es
|
|
|
|
  
Sobre la RTICC Programas RTICC Ofertas de empleo y Agenda Seguimiento científico
Red Temática de Investigación Cooperativa en Cáncer · © Copyright 2013 · sec.rticc[arrroba]usal.es · diseño web: detrazos
RSS